These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke. Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968 [TBL] [Abstract][Full Text] [Related]
6. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Sumii T; Lo EH Stroke; 2002 Mar; 33(3):831-6. PubMed ID: 11872911 [TBL] [Abstract][Full Text] [Related]
7. Intraarterial administration of norcantharidin attenuates ischemic stroke damage in rodents when given at the time of reperfusion: novel uses of endovascular capabilities. Khan IS; Odom M; Ehtesham M; Colvin D; Quarles CC; McLaughlin B; Singer RJ J Neurosurg; 2016 Jul; 125(1):152-9. PubMed ID: 26544777 [TBL] [Abstract][Full Text] [Related]
8. Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat. Kono S; Deguchi K; Omote Y; Yunoki T; Yamashita T; Kurata T; Ikeda Y; Abe K J Neurosci Res; 2014 Jan; 92(1):46-53. PubMed ID: 24265137 [TBL] [Abstract][Full Text] [Related]
9. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke. García-Culebras A; Palma-Tortosa S; Moraga A; García-Yébenes I; Durán-Laforet V; Cuartero MI; de la Parra J; Barrios-Muñoz AL; Díaz-Guzmán J; Pradillo JM; Moro MA; Lizasoain I Stroke; 2017 Jun; 48(6):1695-1699. PubMed ID: 28428349 [TBL] [Abstract][Full Text] [Related]
10. Effects of Pretreatment with Warfarin or Rivaroxaban on Neurovascular Unit Dissociation after Tissue Plasminogen Activator Thrombolysis in Ischemic Rat Brain. Shang J; Yamashita T; Kono S; Morihara R; Nakano Y; Fukui Y; Li X; Hishikawa N; Ohta Y; Abe K J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):1997-2003. PubMed ID: 27230587 [TBL] [Abstract][Full Text] [Related]
11. A hemorrhagic transformation model of mechanical stroke therapy with acute hyperglycemia in mice. Couret D; Bourane S; Catan A; Nativel B; Planesse C; Dorsemans AC; Ait-Arsa I; Cournot M; Rondeau P; Patche J; Tran-Dinh A; Lambert G; Diotel N; Meilhac O J Comp Neurol; 2018 Apr; 526(6):1006-1016. PubMed ID: 29277912 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of mechanical thrombectomy plus tissue-type plasminogen activator compared with tissue-type plasminogen activator alone for acute ischemic stroke in France. Kaboré N; Marnat G; Rouanet F; Barreau X; Verpillot E; Menegon P; Maachi I; Berge J; Sibon I; Bénard A Rev Neurol (Paris); 2019 Apr; 175(4):252-260. PubMed ID: 30642680 [TBL] [Abstract][Full Text] [Related]
13. Endogenous tissue plasminogen activator increases hemorrhagic transformation induced by heparin after ischemia reperfusion in rat brains. Tang J; Li YJ; Li Q; Mu J; Yang DY; Xie P Neurol Res; 2010 Jun; 32(5):541-6. PubMed ID: 19309545 [TBL] [Abstract][Full Text] [Related]
14. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke. Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413 [TBL] [Abstract][Full Text] [Related]
15. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice. Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993 [TBL] [Abstract][Full Text] [Related]
17. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator. Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667 [TBL] [Abstract][Full Text] [Related]
18. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia. Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925 [TBL] [Abstract][Full Text] [Related]
19. Isoflurane preconditioning inhibits the effects of tissue-type plasminogen activator on brain endothelial cell in an Cheon SY; Kim SY; Kam EH; Lee JH; Kim JM; Kim EJ; Kim TW; Koo BN Int J Med Sci; 2017; 14(5):425-433. PubMed ID: 28539818 [TBL] [Abstract][Full Text] [Related]
20. Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke. Hassanipour M; Zarisfi M; Ehsani V; Allahtavakoli M Life Sci; 2020 Sep; 256():117450. PubMed ID: 32087233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]